Arcadia Biosciences gets Nasdaq notice for falling below $2.5 million stockholders’ equity requirement

• Nasdaq notified Arcadia Biosciences on Aug. 31, 2026 of noncompliance with the $2.5 million minimum stockholders’ equity rule.
• Stockholders’ equity was $633,000 as of June 30, 2026, below Nasdaq Listing Rule 5550(b)(1) requirements.
• Failure to meet alternative listing standards left the company out of compliance with Nasdaq Capital Market continued listing rules.
• Shares remain listed for now; a compliance plan is due within 45 days, by Oct. 15, 2026.
• Nasdaq may grant up to a 180-day extension if the plan is accepted; a rejection can be appealed to a hearings panel.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-383642), on September 04, 2026, and is solely responsible for the information contained therein.